Assessment of Safety and Immunogenicity of a Single Vial Presentation of R21/Matrix-M and Co-Administration With EPI Vaccines

Condition:   Malaria Interventions:   Biological: R21/Matrix-M - single vial formulation;   Biological: R21/Matrix-M - two vial formulation;   Biological: Licensed vaccine - Measles-rubella;   Biological: Licensed vaccine - Yellow fever;   Biological: Licensed vaccine - Pentavalent (diphtheria, tetanus, pertussis, hepatitis B and Hib);   Biological: Licensed vaccine - Oral Polio Vaccine (OPV) Sponsors:   University of Oxford;   Malaria Research and Training Center, Bamako, Mali Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials